Author Archives for Lea Scheppke

Free community webinar about MacTel

November 14, 2024 11:29 am Published by Lea Scheppke

November 14, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database.  ... View Article

Neurotech Provides Update on BLA for NT-501 as a Treatment for Macular Telangiectasia Type 2 (MacTel)

November 14, 2024 9:50 am Published by Lea Scheppke

LMRI would like to share the following press release from Neurotech Pharmaceuticals about the BLA for NT-501 as a treatement... View Article

Neurotech Receives Priority Review of Biologics License Application for NT-501 as a Treatment for Macular Telangiectasia Type 2

June 27, 2024 9:15 am Published by Lea Scheppke

June 20, 2024 LMRI would like to share the news that Neurotech has received Priority Review of Biologics License Application... View Article

What To Expect in a MacTel Imaging Exam

May 2, 2024 2:51 pm Published by Lea Scheppke

April 29, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database.  ... View Article

MacTel SAFE Study

March 7, 2024 11:30 am Published by Lea Scheppke

March 6, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database.  ... View Article

MacTel Project 2023 Annual Meeting Summary

February 6, 2024 6:47 pm Published by Lea Scheppke

February 6, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database.  ... View Article

Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Macular Telangiectasia Type 2 (MacTel) Patients with and without Diabetes

May 29, 2023 5:49 pm Published by Lea Scheppke

Lydia Sauer, Alexandra S Vitale, Rachael S Jacoby, Barbara Hart, Paul S Bernstein.  Retina.  2023 May 29.  doi: 10.1097/IAE.0000000000003851.

iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function

May 10, 2023 4:58 pm Published by Lea Scheppke

Eade KT, Ansell BRE, Giles S, Fallon R, Harkins-Perry S, Nagasaki T, Tzaridis S, Wallace M, Mills EA, Farashi S,... View Article

Macular Telangiectasia Type 2: A Classification System Using Mulit-Modal Imaging MacTel Project Report Number 10

December 14, 2022 10:00 am Published by Lea Scheppke

Emily Y. Chew, Tunde Peto, Traci E. Clemons, Ferenc B. Sallo, Daniel Pauleikhoff, Irene Leung, Glenn J. Jaffe, Tjebo F.C.... View Article

Positive Phase 3 Topline Results Announced for NT-501 Implant in MacTel

November 2, 2022 12:48 pm Published by Lea Scheppke

November 2, 2022 Neurotech Pharmaceuticals, Inc. announces positive Phase 3 topline results for NT-501 implant in macular telangiectaisa type 2... View Article